Colgate-Palmolive Co. 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Colgate-Palmolive Co. for the period ended June 30, 1998. The company operates globally in oral, personal, and household care, as well as pet nutrition. As of July 31, 1998, there were 295,701,719 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q2 1998 | Q2 1997 | 6M 1998 | 6M 1997 |
|---|---|---|---|---|
| Net Sales ($M) | 2,256.5 | 2,300.9 | 4,416.0 | 4,448.0 |
| Gross Profit ($M) | 1,172.6 | 1,168.1 | 2,296.1 | 2,248.7 |
| Gross Margin (%) | 52.0% | 50.8% | 52.0% | 50.6% |
| Net Income ($M) | 203.5 | 175.8 | 399.5 | 345.4 |
| Diluted EPS ($) | 0.62 | 0.54 | 1.22 | 1.06 |
| Operating Cash Flow ($M) | N/A | N/A | 480.9 | 426.8 |
| Net Debt to Capitalization | 53% (Unchanged from Dec 31, 1997) |
Liquidity: Cash and cash equivalents totaled $176.1 million at June 30, 1998, compared to $183.1 million at year-end 1997. Commercial paper outstanding was $854.7 million, classified as long-term debt due to refinancing intent.
Material Changes vs. Prior Period
- Revenue: Q2 1998 sales decreased 2% year-over-year due to foreign currency declines, despite a 3% gain in unit volume. Excluding currency effects, sales would have risen 5%.
- Profitability: Net income increased 15.8% in Q2 and 15.7% for the first half of 1998. Gross margins improved to 52.0% from 50.8% due to product mix and cost reduction programs.
- Expenses: SG&A expenses decreased as a percentage of sales to 36.5% in Q2 1998 from 37.1% in 1997. Interest expense (net) decreased to $44.1 million in Q2 1998 from $47.0 million in 1997.
- Regional Performance:
- Latin America: Sales up 2% (Q2) and 5% (6M) driven by strong volume gains.
- North America: Sales up 9% (Q2, excluding divestitures) driven by new products and advertising.
- Europe: Sales down 3% (Q2) due to currency weakness, though volume grew 1%.
- Asia/Africa: Sales down 14% (Q2) due to devalued currencies and economic contraction; volume decreased 3%.
Outlook, Risks, and Unusual Items
- Accounting Changes: The company is evaluating the impact of FASB Statement No. 133 regarding derivative instruments, effective for fiscal years beginning after June 15, 1999.
- Capital Allocation: The company repurchased $173.7 million of common stock in the first half of 1998 and paid $174.6 million in dividends.
- Risks: Significant exposure to foreign currency fluctuations and economic conditions in Asia/Africa and Russia. Management notes that interim results may not be representative of full-year results.
- Legal: No new legal proceedings disclosed in this filing; reference is made to the 1997 10-K for ongoing matters.
Investor Verification Checklist
- Verify the sustainability of the 3% unit volume growth given the 2% reported sales decline due to currency.
- Confirm the classification of $854.7 million in commercial paper as long-term debt and the company's ability to refinance.
- Monitor the impact of the Asian economic contraction on the Asia/Africa segment's volume recovery.
- Review the 1997 10-K for details on legal proceedings referenced in Item 1.
- Assess the future impact of FASB Statement No. 133 on earnings volatility.